BRIEF published on 02/29/2024 at 20:11, 2 years 4 months ago BRAIN Biotech AG Announces Issuance of EUR 5 Million Convertible Bond Convertible Bonds Shareholder Rights Financial Strategy BRAIN Biotech AG Corporate Financing
PRESS RELEASE published on 02/29/2024 at 20:06, 2 years 4 months ago EQS-Adhoc: BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights BRAIN Biotech AG issues EUR 5 million convertible bond without subscription rights, to be issued on 5 March 2024. Bonds have 6.52% interest rate and due for repayment in 2026 Convertible Bond BRAIN Biotech AG Subscription Rights Interest Rate Repayment
PRESS RELEASE published on 02/28/2024 at 07:30, 2 years 4 months ago 3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 BRAIN Biotech AG reports optimistic outlook for fiscal year 2023/24 with strong start in BioScience business. Quarterly report includes details on revenue and segment performance Revenue Growth Financial Performance BRAIN Biotech AG Fiscal Year 2023/24 BioScience Business
BRIEF published on 02/28/2024 at 07:30, 2 years 4 months ago BRAIN Biotech AG: Review of the first quarter of the 2023/24 financial year Financial Report Organic Growth BRAIN Biotech AG BioScience BioProducts
PRESS RELEASE published on 09/28/2023 at 10:30, 2 years 9 months ago BRAIN Biotech AG: BRAIN Biotech AG´s Akribion Genomics team wins first prize at the “BioRiver Boost!” startup competition
PRESS RELEASE published on 09/14/2023 at 10:30, 2 years 9 months ago BRAIN Biotech AG: BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E®
PRESS RELEASE published on 09/12/2023 at 15:45, 2 years 9 months ago BRAIN Biotech AG: Scientist from BRAIN Biotech AG receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family
PRESS RELEASE published on 08/30/2023 at 07:30, 2 years 10 months ago BRAIN Biotech AG reports solid 9M numbers despite ongoing high R&D investments and more challenging economic conditions
PRESS RELEASE published on 06/28/2023 at 13:00, 3 years ago BRAIN Biotech AG´s Akribion Genomics team successfully competes in Science4Life Venture Cup competition
PRESS RELEASE published on 06/19/2023 at 12:30, 3 years ago Anniversary of BRAIN Biotech AG: 30 years for a bio-based future
Published on 07/11/2026 at 02:50, 1 day 8 hours ago Alaska Energy Metals Reports on At-the-Market Equity Financing Program
Published on 07/11/2026 at 02:00, 1 day 9 hours ago Battery X Metals Presents Positive Preliminary Lithium-Ion Battery Rebalancing Trial Results Demonstrating Significant Estimated Driving Range Improvements and Accelerated Commercialization Progress of its Patent-Pending Lithium-Ion Battery Rebalancing Te
Published on 07/11/2026 at 02:00, 1 day 9 hours ago Discovery Energy Metals Announces Non-Brokered Private Placement Financing
Published on 07/11/2026 at 00:00, 1 day 11 hours ago Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API
Published on 07/11/2026 at 04:00, 1 day 7 hours ago CUHK Achieves Top 20 Global Ranking in QS World University Rankings 2027
Published on 07/10/2026 at 18:40, 1 day 16 hours ago AFX Surpasses $1.1 Billion in Total Trading Volume, Highlighting Capital Efficiency in On-Chain Derivatives
Published on 07/10/2026 at 17:45, 1 day 17 hours ago WYF Launches Global AI Talent Compact at AI for Good Global Summit 2026
Published on 07/10/2026 at 17:14, 1 day 18 hours ago Form 8.3 - SAFESTAY PLC: Opening Position Disclosure
Published on 07/10/2026 at 18:00, 1 day 17 hours ago Half-year liquidity contract statement for CEGEDIM
Published on 07/10/2026 at 10:34, 2 days ago Number of shares and voting rights - June 2026 (In French only)
Published on 07/09/2026 at 18:00, 2 days 17 hours ago Second-quarter 2026 activity: +7% (vs. Q2 2025)
